Acadia Pharmaceutica (ACAD)
$48.00
0.56 (1.18%)
8:18 EST
ACAD Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
5.99B
PE Ratio
-23.08
EPS
-2.08
Volume (Avg. Vol.)
1,420
Day's Range
47.44 - 47.44
52-Week Range
30.02 - 58.72
Dividend & Yield
N/A (N/A)
ACAD Stock Predictions, Articles, and Acadia Pharmaceutica News
- From InvestorPlace
- From the Web
10 Stocks to Buy for an Aging Population
Aging seniors have been put firmly in the crosshairs of the novel coronavirus. These 10 stocks to buy will benefit from this brutal reality.
7 Exciting Biotech Stocks to Buy Now
Many of these biotech companies are beating the Nasdaq Biotech Index. With cutting-edge therapies, these are great names to buy.
5 Top Stock Trades for Wednesday: BA, ACB, PINS
Boeing, Aurora Cannabis, Pinterest, Corning and Acadia Pharmaceuticals were our top stock trades on Wednesday. See the charts now.
7 Rising Healthcare Stocks to Consider
Healthcare stocks recovered throughout 2018 but the recent correction in some big names is creating an entry point.
5 Big Pharma Stocks Investors Love Right Now
The biotechnology and pharmaceutical sectors continue to offer great value for investors, and these five Big Pharma stocks stand out from the crowd.
Why ACADIA Pharmaceuticals Stock Is Falling Today
ACADIA Pharmaceuticals (ACAD) stock was down more than 6% on Monday as an investigation was launched to examine the efficacy of one of its drugs.
Why ACADIA Pharmaceuticals Inc. Stock Is Plunging Today
ACADIA Pharmaceuticals(ACAD) stock was falling hard today on a report with concerns about its Parkinson's drug Nuplazid.
5 Biotech Stocks to Sell Amid the Latest Slaughter
These five biotech stocks are being hit particularly hard right now. Here's what investors should know about each of these stocks to sell.
5 Cheap Biotech Stocks to Snag on the Bounce
Biotech's luck is changing as the trend looks to be upward and outward for the biotech stocks. These are the five to watch.
Is Now the Time to Buy Into These 5 Biotech ETFs?
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out
3 Earnings Reports That Should Be on Your Radar
Earnings season is far from over. In addition to crucial economic indicators, there are a few earnings reports to keep an eye on next week.
3 Big Mergers & Acquisitions That We Could See in 2017
2017 is likely to see quite a few mergers & acquisitions, and companies like BKS, NFLX and ACAD are all ripe for the M&A picking.
Acadia Pharmaceuticals Inc. (ACAD) Flirts With a Pfizer Inc. (PFE) Buyout
Acadia stock took a big leap on rumors that Pfizer (PFE) is interested in a buyout. But ACAD stock investors shouldn't get too excited yet.
Hottest Manufacturing Stocks Now – MBRX ZYNE SID ONVO
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – AKBA ABIO GLMD KMPH
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – OSIR ACAD AKAO VHI
The following stocks were moving the Manufacturing sector today.
16 Best Stocks to Buy Under President Hillary Clinton
Could we see a President Hillary Clinton? According to most polls, that's the likeliest outcome for Nov. 8. Get your portfolio prepared with the 16 best stocks to buy ahead of another White House stint for the Clintons.
19 Biotechnology Stocks to Sell Now
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
10 Biotech Stocks to Put on Your Radar This Quarter
Q4 is usually a winner for biotech stocks, but these stocks could deliver more than their fair share of wins during the coming three months.
32 Biotechnology Stocks to Sell Now
The ratings of 32 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold